Search / Trial NCT06617650

GenerationGemelli: Longitudinal Study for the Evaluation of the Maternal Exposome on the Health of the Newborn and Child

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Sep 26, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Description

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * Being resident for at least two years in the city of Rome, Italy.
  • * Being assisted and giving birth at FPG (presumably referring to a specific hospital).
  • * Meeting the definition of case or control.
  • Definitions:
  • - Cases:
  • Women with single pregnancies diagnosed with late intrauterine growth restriction (≥32 weeks of gestational age), according to the definition of Gordjin et al., in the absence of structural and/or evident organ malformations.
  • Women with spontaneous preterm birth at less than 32+0 weeks of gestational age.
  • - Controls:
  • Full-term pregnant women (gestational age between 37+0 and 41+6 weeks) without intrauterine growth restriction or other structural and/or genetic disorders.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Roma, Italia, Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0